Published in Proc Natl Acad Sci U S A on June 01, 1975
Fractionation of DNA nucleotide transcripts from Moloney sarcoma virus and isolation of sarcoma virus-specific complementary DNA. J Virol (1976) 2.39
Comparative study of different isolates of murine sarcoma virus. J Virol (1979) 1.80
Rate of divergence of cellular sequences homologous to segments of Moloney sarcoma virus. J Virol (1977) 1.65
Structural markers on core protein p30 of murine leukemia virus: functional correlation with Fv-1 tropism. Proc Natl Acad Sci U S A (1978) 1.51
Lysis of oncornaviruses by human serum. Isolation of the viral complement (C1) receptor and identification as p15E. J Exp Med (1978) 1.42
Histone 1 is proximal to histone 2A and to A24. Proc Natl Acad Sci U S A (1979) 1.07
Phosphorylation and nucleic acid binding properties of m1 Moloney murine sarcoma virus-specific pP60gag. J Virol (1977) 1.05
The "sarcoma-specific" region of Moloney murine sarcoma virus 124. Proc Natl Acad Sci U S A (1978) 1.04
Chemical determination of the m1 Moloney sarcoma virus pP60gag gene order: evidence for unique peptides in the carboxy terminus of the polyprotein. Proc Natl Acad Sci U S A (1978) 1.02
Thermolabile protein kinase molecules in a temperature-sensitive murine sarcoma virus pseudotype. Proc Natl Acad Sci U S A (1979) 0.96
Effect of helper virus on the number of murine sarcoma virus DNA copies in infected mammalian cells. J Virol (1977) 0.93
Moloney murine sarcoma virus 349 induces Kaposi's sarcomalike lesions in Balb/c mice. Am J Pathol (1990) 0.93
Analysis of intracellular feline leukemia virus proteins II. Generation of feline leukemia virus structural proteins from precursor polypeptides. J Virol (1977) 0.91
Differential synthesis of mammalian type C viral gene products in infected cells. J Virol (1977) 0.86
Analysis of intracellular feline leukemia virus proteins. I. Identification of a 60,000-dalton precursor of feline leukemia virus p30. J Virol (1976) 0.86
Spleen focus-forming virus: specific neutralization by antisera to certain gag gene-encoded proteins. J Virol (1981) 0.75
Protein measurement with the Folin phenol reagent. J Biol Chem (1951) 1743.91
An evaluation of film detection methods for weak beta-emitters, particularly tritium. Anal Biochem (1970) 27.80
Studies on the nucleic acid sequences of Kirsten sarcoma virus: a model for formation of a mammalian RNA-containing sarcoma virus. J Virol (1973) 5.28
RNA in mammalian sarcoma virus transformed nonproducer cells homologous to murine leukemia virus RNA. Virology (1973) 5.04
Infection of an established mouse bone marrow cell line (JLS-V9) with Rauscher and Moloney murine leukemia viruses. Cancer Res (1967) 4.82
Structural proteins of mammalian oncogenic RNA viruses: multiple antigenic determinants of the major internal protein and envelope glycoprotein. J Virol (1974) 3.91
Biosynthesis of Rauscher leukemia viral proteins. Cell (1975) 3.57
Identification of a large polypeptide precursor of avian oncornavirus proteins. Proc Natl Acad Sci U S A (1973) 3.07
Simple, quantitative assay for both xenotropic murine leukemia and ecotropic feline leukemia viruses. J Virol (1974) 2.84
Proteins of the murine C-type RNA tumour viruses: isolation of a group-specific antigen by isoelectric focusing. J Gen Virol (1970) 2.80
Large-volume purification of tumor viruses by use of zonal centrifuges. Appl Microbiol (1972) 2.74
A transmissible virus-induced lymphocytic leukemia of the cat. J Natl Cancer Inst (1969) 2.66
Isolation of RD-114-like oncornavirus from a cat cell line. J Virol (1973) 2.61
Properties of clonal lines of murine sarcoma virus transformed Balb-3T3 cells. Virology (1969) 2.40
Isolation of proteins by gel filtration in 6M guanidinium chloride: application to RNA tumor viruses. Anal Biochem (1974) 1.70
Polypeptides of mammalian oncornaviruses. II Characterization of murine leukemia virus polypeptide (p 15) bearing interspecies reactivity. Virology (1975) 1.63
Revertants of mouse cells transformed by murine sarcoma virus. I. Characterization of flat and transformed sublines without a rescuable murine sarcoma virus. Virology (1972) 1.59
Comparison of murine sarcoma viruses in nonproducer and S + L - -transformed cells. J Virol (1972) 1.44
Isolation of human amnion cells transformed by rescuable murine sarcoma virus. Nat New Biol (1973) 1.41
Murine type-C virus group-specific antigens: interstrain immunochemical, biophysical, and amino acid sequence differences. J Virol (1974) 1.27
Properties of mouse leukemia viruses. I. Characterization of various antisera and serological identification of viral components. Virology (1972) 1.25
Detection of some murine leukemia virus antigens in virus particles derived from 3T3 cells transformed only by murine sarcoma virus. Virology (1972) 1.06
Number and molecular weights of foot-and-mouth disease virus capsid proteins and the effects of maleylation. J Virol (1971) 1.05
Structural aberrations in T-even bacteriophage. V. Effects of canavanine on the maturation and utilization of specific gene products. J Virol (1974) 0.91
Aberrant viruses in cells infected with murine sarcoma virus-feline leukemia virus. J Natl Cancer Inst (1975) 0.80
Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor. Science (1998) 10.53
Transformation of mammalian cells by constitutively active MAP kinase kinase. Science (1994) 8.69
Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science (1991) 8.68
Antibodies that inhibit fusion of human immunodeficiency virus-infected cells bind a 24-amino acid sequence of the viral envelope, gp120. Proc Natl Acad Sci U S A (1988) 8.40
Nucleotide sequences of integrated Moloney sarcoma provirus long terminal repeats and their host and viral junctions. Proc Natl Acad Sci U S A (1980) 7.77
HTLV-III/LAV-neutralizing antibodies to an E. coli-produced fragment of the virus envelope. Science (1986) 6.33
A novel murine oncornavirus with dual eco- and xenotropic properties. Proc Natl Acad Sci U S A (1975) 5.91
Rapid cell culture assay technic for murine leukaemia viruses. Nature (1971) 5.87
Molecular cloning of a new transforming gene from a chemically transformed human cell line. Nature (1984) 5.85
Prospect for prevention of human immunodeficiency virus infection: purified 120-kDa envelope glycoprotein induces neutralizing antibody. Proc Natl Acad Sci U S A (1986) 5.55
Isolation of murine sarcoma virus-transformed mouse cells which are negative for leukemia virus from agar suspension cultures. Int J Cancer (1970) 5.48
Characterization of envelope and core structural gene products of HTLV-III with sera from AIDS patients. Science (1985) 5.42
Properties of a normal mouse cell DNA sequence (sarc) homologous to the src sequence of Moloney sarcoma virus. Science (1980) 5.30
Construction and characterization of a recombinant plasmid encoding the gene for the thymidine kinase of Herpes simplex type 1 virus. Gene (1979) 5.09
Restricted neutralization of divergent human T-lymphotropic virus type III isolates by antibodies to the major envelope glycoprotein. Proc Natl Acad Sci U S A (1986) 4.68
Abnormal centrosome amplification in the absence of p53. Science (1996) 4.60
Activation of the transforming potential of a normal cell sequence: a molecular model for oncogenesis. Science (1981) 4.27
Function of c-mos proto-oncogene product in meiotic maturation in Xenopus oocytes. Nature (1988) 4.24
Mechanism of met oncogene activation. Cell (1986) 4.20
The c-mos proto-oncogene product is a cytostatic factor responsible for meiotic arrest in vertebrate eggs. Nature (1989) 4.13
Construction of a general human chromosome jumping library, with application to cystic fibrosis. Science (1987) 3.87
Simple, rapid, quantitative, syncytium-forming microassay for the detection of human immunodeficiency virus neutralizing antibody. AIDS Res Hum Retroviruses (1987) 3.67
Inactivation of LRG-47 and IRG-47 reveals a family of interferon gamma-inducible genes with essential, pathogen-specific roles in resistance to infection. J Exp Med (2001) 3.64
Cloning of herpes simplex type 1 DNA fragments in a bacteriophage lambda vector. Science (1979) 3.47
The human met oncogene is related to the tyrosine kinase oncogenes. Nature (1985) 3.46
Emergence of viruses resistant to neutralization by V3-specific antibodies in experimental human immunodeficiency virus type 1 IIIB infection of chimpanzees. J Virol (1990) 3.35
Biological activity of cloned Moloney sarcoma virus DNA: Terminally redundant sequences may enhance transformation efficiency. Proc Natl Acad Sci U S A (1980) 3.29
Wip1, a novel human protein phosphatase that is induced in response to ionizing radiation in a p53-dependent manner. Proc Natl Acad Sci U S A (1997) 3.19
Structures of two spliced herpes simplex virus type 1 immediate-early mRNA's which map at the junctions of the unique and reiterated regions of the virus DNA S component. J Virol (1981) 3.19
Human DNA sequence homologous to the transforming gene (mos) of Moloney murine sarcoma virus. Proc Natl Acad Sci U S A (1982) 3.14
Genomic instability and apoptosis are frequent in p53 deficient young mice. Oncogene (1997) 3.01
Quantitative infectivity assay for HIV-1 and-2. Nature (1988) 3.01
Cloning of integrated Moloney sarcoma proviral DNA sequences in bacteriophage lambda. Proc Natl Acad Sci U S A (1979) 2.98
Activating mutations for the met tyrosine kinase receptor in human cancer. Proc Natl Acad Sci U S A (1997) 2.92
Mos stimulates MAP kinase in Xenopus oocytes and activates a MAP kinase kinase in vitro. Mol Cell Biol (1993) 2.87
Nucleotide sequences in mouse DNA and RNA specific for Moloney sarcoma virus. Proc Natl Acad Sci U S A (1976) 2.86
Simple, quantitative assay for both xenotropic murine leukemia and ecotropic feline leukemia viruses. J Virol (1974) 2.84
Pathogen-specific loss of host resistance in mice lacking the IFN-gamma-inducible gene IGTP. Proc Natl Acad Sci U S A (2000) 2.80
Isolation of RD-114-like oncornavirus from a cat cell line. J Virol (1973) 2.61
The product of the mos proto-oncogene as a candidate "initiator" for oocyte maturation. Science (1989) 2.58
Tumorigenicity of the met proto-oncogene and the gene for hepatocyte growth factor. Mol Cell Biol (1992) 2.53
Met receptor tyrosine kinase: enhanced signaling through adapter proteins. Oncogene (2000) 2.52
DNA sequence of an immediate-early gene (IEmRNA-5) of herpes simplex virus type I. Nucleic Acids Res (1982) 2.50
Specific proteolysis of the c-mos proto-oncogene product by calpain on fertilization of Xenopus eggs. Nature (1989) 2.47
Degradation of the Met tyrosine kinase receptor by the ubiquitin-proteasome pathway. Mol Cell Biol (1997) 2.43
Structure of varicella-zoster virus DNA. J Virol (1981) 2.43
Fractionation of DNA nucleotide transcripts from Moloney sarcoma virus and isolation of sarcoma virus-specific complementary DNA. J Virol (1976) 2.39
Invasiveness and metastasis of NIH 3T3 cells induced by Met-hepatocyte growth factor/scatter factor autocrine stimulation. Proc Natl Acad Sci U S A (1994) 2.36
c-mos proto-oncogene RNA transcripts in mouse tissues: structural features, developmental regulation, and localization in specific cell types. Mol Cell Biol (1987) 2.35
A novel germ line juxtamembrane Met mutation in human gastric cancer. Oncogene (2000) 2.35
Identification of HTLV-III/LAV sor gene product and detection of antibodies in human sera. Science (1986) 2.35
Met and hepatocyte growth factor/scatter factor expression in human gliomas. Cancer Res (1997) 2.30
Persistent infection of chimpanzees with human immunodeficiency virus: serological responses and properties of reisolated viruses. J Virol (1987) 2.28
Transformation of mouse 3T3 cells by murine sarcoma virus: release of virus-like particles in the absence of replicating murine leukemia helper virus. Proc Natl Acad Sci U S A (1971) 2.26
Helper T-cell antigenic site identification in the acquired immunodeficiency syndrome virus gp120 envelope protein and induction of immunity in mice to the native protein using a 16-residue synthetic peptide. Proc Natl Acad Sci U S A (1987) 2.25
Evidence that levels of presenilins (PS1 and PS2) are coordinately regulated by competition for limiting cellular factors. J Biol Chem (1997) 2.24
Deoxyribonucleic acid base composition and homology studies of Leptospira. J Bacteriol (1969) 2.08
The met proto-oncogene receptor and lumen formation. Science (1992) 2.08
Enhanced tumorigenicity and invasion-metastasis by hepatocyte growth factor/scatter factor-met signalling in human cells concomitant with induction of the urokinase proteolysis network. Mol Cell Biol (1996) 2.05
Normal DBA/2 mouse cells synthesize a glycoprotein which interferes with MCF virus infection. Virology (1982) 2.02
Meiotic initiation by the mos protein in Xenopus. Nature (1992) 2.00
Isolation and identification of a helper virus found in the Moloney sarcoma-leukemia virus complex. J Natl Cancer Inst (1969) 1.96
Purified envelope glycoproteins from human immunodeficiency virus type 1 variants induce individual, type-specific neutralizing antibodies. J Virol (1988) 1.95
New method for detecting cellular transforming genes. Science (1982) 1.92
Hepatocyte growth factor/scatter factor-Met signaling in tumorigenicity and invasion/metastasis. J Mol Med (Berl) (1996) 1.91
In vitro generation of an HTLV-III variant by neutralizing antibody. J Immunol (1986) 1.91
Nucleic acid similarities among Pseudomonas pseudomallei, Pseudomonas multivorans, and Actinobacillus mallei. J Bacteriol (1970) 1.88
Sodium dodecylsulfate-dependent anomalies in gel electrophoresis: alterations in the banding patterns of foot-and-mouth disease virus polypeptides. Anal Biochem (1974) 1.81
Tissue distribution of products of the mouse decay-accelerating factor (DAF) genes. Exploitation of a Daf1 knock-out mouse and site-specific monoclonal antibodies. Immunology (2001) 1.79
Expression of c-mos proto-oncogene transcripts in mouse tissues. Nature (1985) 1.78
The Met proto-oncogene mesenchymal to epithelial cell conversion. Science (1994) 1.77
The mutationally activated Met receptor mediates motility and metastasis. Proc Natl Acad Sci U S A (1998) 1.76
The inducibly expressed GTPase localizes to the endoplasmic reticulum, independently of GTP binding. J Biol Chem (1997) 1.75
Titration patterns of a murine sarcoma-leukemia virus complex: evidence for existence of competent sarcoma virions. Science (1968) 1.73
Neutralization of homologous and heterologous oncornaviruses by antisera against the p15(E) and gp71 polypeptides of Friend murine leukemia virus. Virology (1976) 1.73
HTLV-III large envelope protein (gp120) suppresses PHA-induced lymphocyte blastogenesis. J Immunol (1987) 1.69
Agreement between general practice prescription data and self-reported use of hormone replacement therapy and treatment for various illnesses. J Epidemiol Biostat (2001) 1.68
Identification of a novel GTPase, the inducibly expressed GTPase, that accumulates in response to interferon gamma. J Biol Chem (1996) 1.66
Rate of divergence of cellular sequences homologous to segments of Moloney sarcoma virus. J Virol (1977) 1.65
Characterization of the TPR-MET oncogene p65 and the MET protooncogene p140 protein-tyrosine kinases. Proc Natl Acad Sci U S A (1988) 1.64
HLA-DR is involved in the HIV-1 binding site on cells expressing MHC class II antigens. J Immunol (1988) 1.63
Three additional DNA polymorphisms in the met gene and D7S8 locus: use in prenatal diagnosis of cystic fibrosis. J Pediatr (1987) 1.63
Signaling pathways in Ras-mediated tumorigenicity and metastasis. Proc Natl Acad Sci U S A (1998) 1.63
Evidence that MIG-6 is a tumor-suppressor gene. Oncogene (2006) 1.62
The von Hippel-Lindau tumor suppressor gene inhibits hepatocyte growth factor/scatter factor-induced invasion and branching morphogenesis in renal carcinoma cells. Mol Cell Biol (1999) 1.62
Structure, tissue-specific expression, and transforming activity of the mouse met protooncogene. Cell Growth Differ (1990) 1.62